
Converge Bio Raises $25M for AI-Driven Drug Discovery
Converge Bio is rewriting the rules of drug discovery with its AI-powered platform, and a whopping $25 million in Series A funding is just the beginning. A New Era in Drug Development Pharmaceutical companies have long relied on laborious, trial-and-error approaches to develop new treatments. But Converge Bio is changing the game with its cutting-edge…









